1. Home
  2. RMCO vs NEPH Comparison

RMCO vs NEPH Comparison

Compare RMCO & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royalty Management Holding Corporation

RMCO

Royalty Management Holding Corporation

HOLD

Current Price

$2.32

Market Cap

35.2M

Sector

Miscellaneous

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

N/A

Current Price

$3.52

Market Cap

39.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RMCO
NEPH
Founded
2021
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.2M
39.0M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
RMCO
NEPH
Price
$2.32
$3.52
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $6.25
AVG Volume (30 Days)
7.0K
★ 38.5K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
★ 0.43%
N/A
EPS Growth
N/A
★ 1000.00
EPS
N/A
★ 0.12
Revenue
$4,949,916.00
★ $18,789,000.00
Revenue This Year
$61.62
$17.81
Revenue Next Year
$62.50
$15.90
P/E Ratio
★ N/A
$29.58
Revenue Growth
★ 513.30
32.67
52 Week Low
$1.74
$2.66
52 Week High
$5.00
$6.42

Technical Indicators

Market Signals
Indicator
RMCO
NEPH
Relative Strength Index (RSI) 36.17 45.33
Support Level $2.11 $2.86
Resistance Level $2.46 $3.78
Average True Range (ATR) 0.09 0.29
MACD -0.02 0.03
Stochastic Oscillator 26.56 67.05

Price Performance

Historical Comparison
RMCO
NEPH

About RMCO Royalty Management Holding Corporation

Royalty Management Holding Corp is formed to invest or purchase assets that have near and medium-term income potential to provide RMC with accretive cash flow from which it can reinvest in new assets or expand cash flow from those existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: